Sequencing Core

$361,703U19FY2012AINIH

Fred Hutchinson Cancer Research Center, Seattle WA

Investigators

Linked publications, trials & patents

Paper 33276046 Paper 32506752 Paper 31416800 Paper 31204301 Paper 30696625 Paper 30590092 Paper 30391142 Paper 30361514 Paper 30038938 Paper 29878913 Paper 29220353 Paper 29093179 Paper 28984168 Paper 28895855 Paper 28885825 Paper 28873986 Paper 28638104 Paper 28404854 Paper 28239658 Paper 28122027 Paper 27855263 Paper 27762266 Paper 27741222 Paper 27272125 Paper 27031009 Paper 26980728 Paper 26958575 Paper 26908162 Paper 26829887 Paper 26718067 Paper 26372270 Paper 26355737 Paper 26265463 Paper 26019725 Paper 25754473 Paper 25648264 Paper 24936916 Paper 24827459 Paper 24724628 Paper 24714473 Paper 24594780 Paper 24510269 Paper 24496438 Paper 24485787 Paper 24390339 Paper 24287598 Paper 24287493 Paper 24285304 Paper 24284880 Paper 24220323 Paper 24121685 Paper 24025078 Paper 24003063 Paper 23861664 Paper 23719296 Paper 23478911 Paper 23394377 Paper 23364313 Paper 23182074 Paper 23164935 Paper 22941364 Paper 22898598 Paper 22799276 Paper 22718830 Paper 22684507 Paper 22305563 Trial NCT00968630 Patent 8673557 Patent 12378546 Patent 11959073 Patent 11873479 Patent 11008565 Patent 10995332 Patent 10947529 Patent 10828333 Patent 10745690 Patent 10745689 Patent 10745688 Patent 10350245

Abstract

In this core, Dr. Bumgarner's group will be responsible for performing sequencing analysis of viral populations isolated from a primate model of hematopoetic cell transplant (HCT) aimed at a targeted cure for HIV.

View original record on NIH RePORTER →